Evidence mapPaperPMID 32634818Full record

GuidelinePediatric research2020

COVID-19 PICU guidelines: for high- and limited-resource settings.

Saraswati Kache, Mohammod Jobayer Chisti, Felicity Gumbo, Ezekiel Mupere, Xia Zhi, Karthi Nallasamy, Satoshi Nakagawa, Jan Hau Lee, Matteo Di Nardo, Pedro de la Oliva and 5 more

Open access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in Pediatric research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Minimizing Societal Cost of Epidemics: Optimal Catastrophe Insurance Compensation Allocation.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  7. Observational
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Respiratory Care in Children with COVID-19.Journal of pediatric intensive care · 2023
    Review
  13. Article
  14. Article
  15. COVID-19 in Children.Pediatric clinics of North America · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 14 institutions in 11 countries.

Saraswati KacheDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA. skache@stanford.edu.
Mohammod Jobayer ChistiIntensive Care Unit and Clinical Research, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Felicity GumboDepartment of Pediatrics and Child Health, College of Health Sciences University of Zimbabwe, Harare, Zimbabwe.
Ezekiel MupereDepartment of Pediatrics and Child Health, School of Medicine College of Health Sciences, Makerere University, Kampala, Uganda.
Xia ZhiDepartment of Pediatric Intensive Care Unit, Maternal and Child Health Hospital of Hubei Province, Wuhan City, Hubei Province, China.
Karthi NallasamyDepartment of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab, India.
Satoshi NakagawaCritical Care Medicine, National Center for Child Health & Development, Tokyo, Japan.
Jan Hau LeeChildren's Intensive Care Unit, KK Women's and Children's Hospital, Duke-NUS Medical School, Singapore, Singapore.
Matteo Di NardoPediatric Intensive Care Unit, Children's Hospital Bambino Gesù, Rome, Italy.
Pedro de la OlivaPediatric Intensive Care Department, Hospital Universitario La Paz, Department of Pediatrics Medical School, Universidad Autónoma de Madrid, Madrid, Spain.
Chhavi KatyalPediatric Critical Care Medicine, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA.
Kanwaljeet J S AnandDepartment of Pediatrics, Anesthesiology, Perioperative & Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Daniela Carla de SouzaPediatric Intensive Care Unit, University of São Paulo & Hospital Sírio Libanês-, São Paulo, Brazil.
Vanessa Soares LanziottiPediatric Intensive Care Unit & Research and Education Division/Maternal and Child Health Postgraduate Program, Federal University of Rio De Janeiro, Rio De Janeiro, Brazil.
Joseph CarcilloDepartments of Critical Care Medicine and Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Stanford University · USAlbert Einstein College of Medicine · USBambino Gesù Children's Hospital · ITHospital Sírio-Libanês · BRHubei Provincial Women and Children's Hospital · CNInternational Centre for Diarrhoeal Disease Research · BDKK Women's and Children's Hospital · SGMakerere University · UGNational Center For Child Health and Development · JPPost Graduate Institute of Medical Education and Research · INUniversidad Autónoma de Madrid · ESUniversidade Federal do Rio de Janeiro · BRUniversity of Pittsburgh · USUniversity of Zimbabwe · ZW

Funding

Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure RenewalR01GM108618 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$485k
NIGMS NIH HHS R01 GM108618
6 · The paper itself

Abstract

backgroundFewer children than adults have been affected by the COVID-19 pandemic, and the clinical manifestations are distinct from those of adults. Some children particularly those with acute or chronic co-morbidities are likely to develop critical illness. Recently, a multisystem inflammatory syndrome (MIS-C) has been described in children with some of these patients requiring care in the pediatric ICU.

methodsAn international collaboration was formed to review the available evidence and develop evidence-based guidelines for the care of critically ill children with SARS-CoV-2 infection. Where the evidence was lacking, those gaps were replaced with consensus-based guidelines.

resultsThis process has generated 44 recommendations related to pediatric COVID-19 patients presenting with respiratory distress or failure, sepsis or septic shock, cardiopulmonary arrest, MIS-C, those requiring adjuvant therapies, or ECMO. Evidence to explain the milder disease patterns in children and the potential to use repurposed anti-viral drugs, anti-inflammatory or anti-thrombotic therapies are also described.

conclusionBrief summaries of pediatric SARS-CoV-2 infection in different regions of the world are included since few registries are capturing this data globally. These guidelines seek to harmonize the standards and strategies for intensive care that critically ill children with COVID-19 receive across the world. IMPACT: At the time of publication, this is the latest evidence for managing critically ill children infected with SARS-CoV-2. Referring to these guidelines can decrease the morbidity and potentially the mortality of children effected by COVID-19 and its sequalae. These guidelines can be adapted to both high- and limited-resource settings.

Indexed as

BetacoronavirusPandemicsAdolescentAfricaAmericasAntiviral AgentsAsiaCardiopulmonary ResuscitationChildChild, PreschoolCombined Modality TherapyComorbidityCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentCritical CareAntiviral Agents

Identifiers

PMID32634818
PMCPMC7577838
OpenAlexW3038227050

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.